ramucirumab,pembrolizumab
eli lilly,merck
['s1800a', 'hlb']
happy to share our editorial on the #asco22 s1800a study presentation! . 
Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.